Join the Polycythemia Vera group to help and get support from people like you.
Polycythemia Vera News
New Experimental Drug, Rusfertide, Could Be Big Advance Against Rare Blood Cancer
MONDAY, Feb. 26, 2024 – Polycythemia vera is a rare form of blood cancer with few good treatment options, but that may soon change based on the results of a new clinical trial. An injected...
Rusfertide Treatment Beneficial for Patients With Polycythemia Vera
THURSDAY, Feb. 22, 2024 – For patients with polycythemia vera, rusfertide treatment reduces the use of phlebotomy and maintains hematocrit of less than 45 percent, according to a study published in...
FDA Approves Besremi (ropeginterferon alfa-2b-njft) for the Treatment of Adults With Polycythemia Vera
BURLINGTON, Mass.--(BUSINESS WIRE) November 12, 2021 --PharmaEssentia Corporation (TPEx: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific...
FDA Approves Jakafi (ruxolitinib) for Polycythemia Vera
December 4, 2014 – The U.S. Food and Drug Administration today approved a new use for Jakafi (ruxolitinib) to treat patients with polycythemia vera, a chronic type of bone marrow disease. Jakafi is...
Ask a question
To post your own question to this support group, sign in or create an account.